Mallinckrodt Plc Ordinary Share (MNK) 116.72 $MNK Why

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mallinckrodt Plc Ordinary Share (MNK) 116.72 $MNK

Why Mallinckrodt (MNK) Could Beat Earnings Estimates Again - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 7:59AM CST
Mallinckrodt has a nice short-term history of crushing expectations, and could be a great candidate for another beat
MNK: 116.72 (-2.89)

The Top Mid-Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Fri Feb 27, 2:04AM CST

SIRO: 90.82 (-0.20), JCOM: 67.25 (-0.66), SKX: 68.14 (-0.62), CIEN: 20.92 (+0.01), NUVA: 45.75 (+0.76), LII: 104.26 (-0.02), WWW: 30.56 (+0.34), SIVB: 122.90 (-1.01), CSL: 93.07 (-1.11), DLX: 66.55 (-1.40), MNK: 116.72 (-2.89), CAVM: 68.49 (+0.09), CBL: 20.02 (+0.17), EV: 42.10 (+0.49), IMAX: 34.97 (-0.04), WWAV: 40.95 (+0.07), CBRL: 151.03 (+0.01), PRXL: 64.46 (-0.80), KNX: 33.06 (-0.11), HAE: 44.46 (-0.79), TFX: 121.69 (+0.47), FLO: 21.64 (+0.21), FHN: 14.29 (-0.18), BIG: 47.71 (-0.02), NVR: 1,332.00 (-8.98), WEN: 11.09 (-0.22)

FDA accepts Teva's NDA for abuse-deterrent opioid
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 8:42AM CST

MNK: 116.72 (-2.89), LCI: 62.40 (-2.77), ACT: 291.36 (+1.58), EGLT: 15.01 (+0.03), ZGNX: 1.68 (+0.03), PFE: 34.32 (-0.27), ABBV: 60.50 (-0.02), TEVA: 57.02 (+0.53), ALKS: 70.25 (-0.98), ACUR: 0.85 (+0.09)

Lannett Joins Big-Game Hunt For Drugmaker Acquisitions
at Investor's Business Daily - Tue Feb 24, 2:58PM CST
Generic-drug maker Lannett Co. in recent quarters has surged on price increases and, more recently, volume gains on key prescription medications. Like some other drug companies in the news this week, Lannett (LCI) is on the hunt for potential...
AGN: 232.74 (+0.34), MNK: 116.72 (-2.89), LCI: 62.40 (-2.77), VRX: 197.48 (-3.77), ACT: 291.36 (+1.58), AKRX: 53.81 (+0.34), SHPG: 241.91 (-5.93), SLXP: 157.20 (+0.25), NPSP: 45.97 (+0.01), MYL: 57.33 (+0.09), BMY: 60.92 (-0.54)

Mallinckrodt: Strong Growth From Transformative Acquisitions Paying Off
Brad Kenagy - at Seeking Alpha - Tue Feb 24, 6:22AM CST

MNK: 116.72 (-2.89)

Five Top-Rated Medical Stocks To Keep Monitoring
at Investor's Business Daily - Mon Feb 23, 5:22PM CST
Most Stock Spotlight names are well extended past proper buy points as the market improves, but it doesn't hurt to keep watching them for a new opportunity to buy. Two generic drugmakers on the list, Akorn (AKRX) and Mallinckrodt (MNK), are extended....
MNK: 116.72 (-2.89), LCI: 62.40 (-2.77), ACT: 291.36 (+1.58), AKRX: 53.81 (+0.34), MYL: 57.33 (+0.09)

Tracking John Paulson's Paulson & Company Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - Mon Feb 23, 3:36AM CST

TLM: 7.78 (+0.05), HHC: 149.79 (+1.59), AET: 99.55 (+0.24), STAY: 19.30 (-0.24), DLTR: 79.68 (+0.64), AEM: 32.15 (+0.04), NPSP: 45.97 (+0.01), DG: 72.62 (+0.43), ABBV: 60.50 (-0.02), TMUS: 33.03 (+0.55), DXM: 6.75 (-0.02), CODE: 36.08 (-0.11), MNK: 116.72 (-2.89), GOLD: 79.19 (+0.19), NCQ: 0.60 (+0.01), COV: 106.71 (-1.36), AU: 11.27 (+0.11), SLXP: 157.20 (+0.25), IAG: 2.45 (+0.09), MYL: 57.33 (+0.09), FDO: 78.74 (+0.13), MGM: 21.73 (-0.22), HIG: 40.96 (-0.03), NG: 3.72 (+0.07), EQIX: 224.18 (-2.22), OAS: 14.33 (-0.23), PETM: 82.91 (+0.01), ACT: 291.36 (+1.58), MDT: 77.59 (-1.22), BPOP: 34.51 (+1.77), ENZY: 8.29 (+0.11), GFI: 4.65 (+0.04), CZR: 10.60 (-0.19), CVC: 18.78 (-0.10), CIE: 10.24 (+0.43), AGN: 232.74 (+0.34), CACQ: 7.39 (-0.13), T: 34.56 (+0.06), ECA: 13.05 (-0.03), S: 5.12 (+0.35), FCH: 10.77 (+0.12), SHPG: 241.91 (-5.93), DTV: 88.60 (+0.25), KMDA: 4.51 (-0.01), ANV: 1.00 (-0.03), BAC: 15.81 (-0.23), GRFS: 32.76 (-0.55), HCA: 71.54 (-0.73), POST: 49.48 (unch), RDN: 15.81 (-0.14), BEE: 13.12 (unch), GLD: 116.16 (+0.09), RLGY: 46.00 (-0.47), HMHC: 19.78 (-0.28), MTG: 9.13 (unch), CMCSA: 59.38 (+0.23), SBGL: 10.59 (+0.17), BABA: 85.12 (-0.25)

The Top Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Mon Feb 23, 2:37AM CST

ELLI: 52.85 (-0.39), JCOM: 67.25 (-0.66), CAH: 87.99 (-0.18), CIEN: 20.92 (+0.01), AET: 99.55 (+0.24), ANAC: 43.50 (-0.60), CSL: 93.07 (-1.11), HSIC: 140.05 (-0.39), MNK: 116.72 (-2.89), CAVM: 68.49 (+0.09), HAS: 62.31 (-0.19), BCR: 169.14 (-1.80), MCHP: 51.27 (-0.20), MYL: 57.33 (+0.09), DEPO: 21.95 (-0.65), HRL: 58.51 (+0.05), CSX: 34.31 (unch), DYAX: 15.11 (-0.37), LVLT: 53.86 (+0.47), CBRL: 151.03 (+0.01), MTSI: 33.72 (-0.27), AZO: 642.68 (-2.29), KNX: 33.06 (-0.11), HAE: 44.46 (-0.79), FSL: 36.11 (+0.14), BDX: 146.72 (-1.82), ACT: 291.36 (+1.58), BLL: 71.71 (-0.71), NUVA: 45.75 (+0.76), CDW: 37.63 (-0.54), ADBE: 79.10 (+0.14), AFFX: 11.70 (-0.03), AGN: 232.74 (+0.34), ANTM: 146.45 (-0.27), APH: 56.46 (-0.34), INFA: 42.94 (-0.51), EXAM: 40.40 (-0.20), LII: 104.26 (-0.02), CNMD: 51.30 (+0.04), BJRI: 52.22 (-0.10), DLX: 66.55 (-1.40), ABT: 47.37 (-0.24), ENDP: 85.60 (+0.36), ABCO: 54.12 (-0.43), DIOD: 28.49 (-0.30), LEG: 45.05 (-0.03), DIS: 104.08 (-0.48), GLW: 24.40 (-0.07), MAR: 83.10 (-0.12), IMAX: 34.97 (-0.04), CNC: 61.46 (+0.28), IGV: 98.31 (-0.43), CTAS: 83.48 (-0.53), FLT: 153.43 (-1.98), CMCSA: 59.38 (+0.23), FLO: 21.64 (+0.21), CRM: 69.38 (-0.86)

10 Stocks John Paulson Loves: Allergan, Time Warner Cable and More
at The Street - Thu Feb 19, 7:46AM CST
Here's a closer look at 10 stocks Paulson & Co. bought in the most recently reported quarter.
MNK: 116.72 (-2.89), AGN: 232.74 (+0.34), WLL: 33.83 (-0.17), ACT: 291.36 (+1.58), TLM: 7.78 (+0.05), SLXP: 157.20 (+0.25), DTV: 88.60 (+0.25), MYL: 57.33 (+0.09), TWC: 154.05 (+1.65), TMUS: 33.03 (+0.55)

Actavis Tops Views, Announces Name Change To Allergan
at Investor's Business Daily - Wed Feb 18, 4:34PM CST
Irish drugmaker Actavis topped quarterly sales and profit views Wednesday and said that it will change its corporate name to better reflect its transition from a provider mostly of generic drugs to a branded pharmaceutical firm. The Dublin-based...
MNK: 116.72 (-2.89), AGN: 232.74 (+0.34), LCI: 62.40 (-2.77), ACT: 291.36 (+1.58), AKRX: 53.81 (+0.34)

Elite Pharma set to begin abuse-deterrent opioid Phase 3 trial
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 9:06PM CST

MNK: 116.72 (-2.89), LCI: 62.40 (-2.77), EGLT: 15.01 (+0.03), ACT: 291.36 (+1.58), ZGNX: 1.68 (+0.03), PFE: 34.32 (-0.27), ABBV: 60.50 (-0.02), TEVA: 57.02 (+0.53), ALKS: 70.25 (-0.98), ACUR: 0.85 (+0.09)

FDA accepts Collegium's NDA for abuse-deterrent opioid
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 7:40AM CST

MNK: 116.72 (-2.89), LCI: 62.40 (-2.77), EGLT: 15.01 (+0.03), ACT: 291.36 (+1.58), ZGNX: 1.68 (+0.03), PFE: 34.32 (-0.27), ABBV: 60.50 (-0.02), TEVA: 57.02 (+0.53), ALKS: 70.25 (-0.98), ACUR: 0.85 (+0.09)

The Best Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sun Feb 15, 1:02PM CST

OCR: 76.74 (-0.07), ELLI: 52.85 (-0.39), CAG: 34.98 (+0.31), JCOM: 67.25 (-0.66), CAH: 87.99 (-0.18), AET: 99.55 (+0.24), PKG: 82.86 (+0.15), CAKE: 47.52 (-1.13), DAN: 21.85 (-0.17), CSL: 93.07 (-1.11), AAN: 29.81 (+0.14), HSIC: 140.05 (-0.39), MNK: 116.72 (-2.89), CAVM: 68.49 (+0.09), HAS: 62.31 (-0.19), BCR: 169.14 (-1.80), MCHP: 51.27 (-0.20), COLM: 55.89 (-0.13), NXPI: 84.89 (-0.07), CSX: 34.31 (unch), LVLT: 53.86 (+0.47), PFPT: 56.64 (-0.69), AZO: 642.68 (-2.29), IRWD: 15.45 (-0.58), HAE: 44.46 (-0.79), EL: 82.67 (+0.39), FSL: 36.11 (+0.14), ACT: 291.36 (+1.58), BDX: 146.72 (-1.82), BLL: 71.71 (-0.71), BWLD: 191.12 (-0.62), NUVA: 45.75 (+0.76), CDW: 37.63 (-0.54), AFFX: 11.70 (-0.03), AGN: 232.74 (+0.34), DPS: 78.79 (+0.60), APH: 56.46 (-0.34), INFA: 42.94 (-0.51), EXAM: 40.40 (-0.20), GMED: 24.28 (-0.78), LII: 104.26 (-0.02), CNMD: 51.30 (+0.04), BJRI: 52.22 (-0.10), HBI: 127.54 (-1.37), DLX: 66.55 (-1.40), ORLY: 208.13 (-1.21), DIOD: 28.49 (-0.30), LEG: 45.05 (-0.03), DIS: 104.08 (-0.48), GLW: 24.40 (-0.07), DISH: 75.04 (-1.72), LEA: 108.92 (-0.11), IMAX: 34.97 (-0.04), CNC: 61.46 (+0.28), PERY: 23.60 (+0.02), CTAS: 83.48 (-0.53), BIG: 47.71 (-0.02)

European Optimism Defies Greece, Ukraine And GDP Views
at Investor's Business Daily - Fri Feb 13, 4:45PM CST
Markets in Europe finished Friday with modest gains for the week after navigating a rush of historic news events. Those events involved another cease-fire in Ukraine's civil war, talks regarding the status of Greece's bailout and fourth-quarter GDP...
MNK: 116.72 (-2.89), CRH: 28.31 (+0.14), KING: 15.79 (-0.16)

FDA accepts Pfizer's NDA for abuse-deterrent opioid
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 10:22AM CST

MNK: 116.72 (-2.89), LCI: 62.40 (-2.77), ACT: 291.36 (+1.58), ZGNX: 1.68 (+0.03), PFE: 34.32 (-0.27), ABBV: 60.50 (-0.02), TEVA: 57.02 (+0.53), ALKS: 70.25 (-0.98)

Anika Therapeutics files Cingal regulatory apps in U.S. and Europe
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 2:42PM CST

MNK: 116.72 (-2.89), FLXN: 22.81 (-0.08), XENE: 19.34 (+0.29), HZNP: 20.53 (+1.46), AMPE: 5.64 (-0.02), CBYL: (), ANIK: 39.92 (-0.04)

6 Big Pharmaceutical Companies You Don't Want In Your Portfolio
at The Street - Tue Feb 10, 7:17AM CST
Which big pharmaceutical stocks should investors stay away from in 2015?
MNK: 116.72 (-2.89), ENDP: 85.60 (+0.36), JAZZ: 170.09 (-5.10), AZN: 68.90 (-0.11), SLXP: 157.20 (+0.25), GSK: 47.42 (-0.42)

Healthcare stock screen of the month: Accelerating after-tax margins
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 11:21AM CST

MNK: 116.72 (-2.89), BIIB: 409.59 (-0.51), VRX: 197.48 (-3.77), BCR: 169.14 (-1.80), EVHC: 36.62 (-0.93), TMO: 130.00 (-0.14), CAH: 87.99 (-0.18), UTHR: 155.05 (-0.53), ILMN: 195.46 (-3.00), ACOR: 33.84 (-1.72), LCI: 62.40 (-2.77), JAZZ: 170.09 (-5.10), SHPG: 241.91 (-5.93), CPHD: 56.84 (-1.60), SYK: 94.75 (+0.35)

Analysts remain bullish on Mallinkrodt
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 12:13PM CST

MNK: 116.72 (-2.89)

Texas AD investigating Mallinckrodt Medicaid pricing
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 9:34AM CST

MNK: 116.72 (-2.89)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Farrin Firm Stands Out Again in Triangle's Fast 50

Updated Category News Views 50

Law Offices of James Scott Farrin in the Spotlight Another triumph for the Law Offices of James Scott Farrin. Not a newbie to recognition, this marks the third time in a row they've landed on the 'Triangle Business Journal's' esteemed 'Fast 50' list. They're the sole law firm among the Triangle's 50 fastest-growing private companies, making waves in a sea usually...

Continue Reading
David Constable Joins Marathon Petroleum Board in 2027

Updated Category News Views 29

Nailing down strategic leadership is a big deal in any industry, and for Marathon Petroleum Corporation (NYSE: MPC), snagging David E. Constable for their board counts as a significant maneuver. Constable stepping into this role effective March 1, 2027, is like a tactical play in a high-stakes game, and here's why it matters. Who's This New Board Player? Well, Constable's...

Continue Reading
Keller Joins JC Behavioral Health Council, RCA Shines

Updated Category News Views 26

RCA's Role in Behavioral Health Standards Kendall Keller just grabbed a prime seat at a table that could shape the future of behavioral healthcare in the U.S. Appointed to the Joint Commission’s (JC) Behavioral Health Care & Human Services Advisory Council, Keller isn’t lounging around. Here’s someone with 18 years under her belt, tasked with steering the ship for...

Continue Reading
XREAL AURA: A New Era of Wired XR Glasses

Updated Category News Views 77

Pioneering the XR Frontier Welcome to another day under the sun of cutting-edge tech, where XREAL's striking a chord with its new wired XR glasses—AURA. First off, don't let the tangled history of tech hype get to you. In the wild world of extended reality, we've seen plenty of flash, not enough substance. But XREAL's hitting the market with AURA, and I gotta say,...

Continue Reading
Digital Art Sparks Future City Visions in Beijing

Updated Category News Views 66

Beijing's Bold Digital Art Venture: A New Era in Creativity Ever felt the jittery buzz of innovation on the cutting edge? That's exactly what visitors experienced in Beijing's 'Spiritual Land: Future World of Inspiration' exhibition at the BOE Yiyun Digital Art Center. Set against the backdrop of the sprawling metropolis, this joint effort between Beijing and Linz aims to...

Continue Reading
Yeastar's AI Innovations Shine at Yeahs Awards 2026

Updated Category News Views 95

Award Recap: The Best of Yeastar’s Yeahs 2026 Blasting out of the gates here with some hefty recognition at the Yeahs Awards 2026—Yeastar is slinging accolades like confetti at a wedding. What’s the deal? It’s all about their partners and their slick moves in Unified Communications (UC). These tech whizzes are racking up milestones in AI, cloud services, and...

Continue Reading
Nicely Network: A Game-Changer for B2B SaaS Marketing

Updated Category News Views 173

Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...

Continue Reading
CloudKeeper Simplifies AI Cost Tracking with FinOps Launch

Updated Category News Views 58

AI Cost Management: A Complex Endeavor Tracking the myriad costs of AI operations can be downright infuriating. Every company dipping its toes in these waters quickly finds itself tangled in a web of fees spanning different models, applications, and cloud services. This tangled mess is about to get some much-needed untangling, thanks to CloudKeeper's latest move. They're...

Continue Reading
HR HealthCare Foundation: New Chapter of Giving

Updated Category News Views 92

HR HealthCare Reaffirms Commitment Through New Foundation The corporate world didn't see this one coming. On October 29, 2026, HR HealthCare, a stalwart in the healthcare products arena, has decided to double down on its benevolent side by establishing the HR HealthCare Foundation. It ain't just about selling widgets anymore; it's about making a genuine impact outside the...

Continue Reading
QuidelOrtho's Podcast: AI & Informatics Elevate Labs

Updated Category News Views 40

Navigating Lab Complexities with QuidelOrtho Who'd have thought a podcast could shake the beakers in a lab? QuidelOrtho Corporation (NASDAQ:QDEL) proves the digital discourse is worth tuning into if you're eyeing diagnostic innovations lately. Episode 62 of their Science Bytes podcast unravels how AI and informatics are shifting gears in laboratory landscapes. The folks...

Continue Reading

Top 5 Most Recently Viewed Articles

How the Fed's Rate Cuts Influence the Stock Market Outlook

Updated Category News Views 108

Understanding the Link Between Rate Cuts and Stock Market Performance As we progress through changing economic conditions, central banks and their policies play a critical role. Tom Lee, a well-known market analyst, highlights a strong connection between Federal Reserve actions and stock market outcomes. Recent conversations among central bankers reflect a growing...

Continue Reading
PET Stock Hits New Low: Analyzing Challenges and Future Prospects

Updated Category News Views 61

Current Market Challenges Facing PET Stock In a challenging market landscape, PET stock has recently reached a new 52-week low of $0.66, clearly indicating a turbulent period. This price point represents a drastic decline, with a staggering 62.01% drop in value observed over the past year. Investors and analysts have been grappling with various issues affecting the...

Continue Reading
Mexico Stock Market: Declines as Key Sectors Struggle

Updated Category News Views 225

Mexico Stock Market Overview Recently, the Mexico stock market exhibited a noticeable decline as key sectors struggled to maintain their footing. The closing session saw a drop in the S&P/BMV IPC, which ultimately fell by 0.53%. This downward trend came after a day where the Industrials, Consumer Goods & Services, and Consumer Staples sectors faced significant losses,...

Continue Reading
Sweet Paris Expands with New Café at Galleria Shopping Center

Updated Category News Views 370

Sweet Paris Crêperie & Café Expands in the Midwest Sweet Paris Crêperie & Café is poised to enhance its presence in the Midwest by opening a new location at the Galleria Shopping Center. This upscale shopping destination is set to host its newest café, bringing the brand's signature dishes and unique dining experience to a broader audience. New Location Details The...

Continue Reading
Veren Inc. Reports Impressive Q3 2024 Performance

Updated Category News Views 45

Overview of Q3 2024 Results Veren Inc. is thrilled to share its operational highlights and financial results for the third quarter of 2024, reflecting a robust performance that showcases the company’s strategic initiatives and operational efficiency. The updates provide insights into Veren's enhanced operational capabilities and its ambitious outlook for the future....

Continue Reading